diacetylmorphine (diamorphine, heroin)
Jump to navigation
Jump to search
Epidemiology
- 2-fold increase in heroin overdoses 2010-2012[2]
- nonmedical use of prescription opioids is a risk factor for heroin use[4] Pharmacokinectics:
- heroin (diacetylmorphine) is rapidly hydrolyzed to 6-monoacetyl morphine, which, in turn, is hydrolyzed to morphine
- both heroin & 6-monoacetyl morphine are more lipid soluble than morphine & more readily cross the blood brain barrier
- intravenous injection of heroin gives a "rush" due to the rapid initial flux of heroin into the brain
- this "rush" is described as a warmth, taste or high with intense pleasure & may be responsible for much of the popularity of heroin & its abuse potential
- after intravenous injection, effects begin in < 1 minute
- an intense euphoria "rush" ensues lasting 45 seconds to several minutes
- after this, there is a period of sedation & tranquility lasting up to 1 hour
- the effects of heroin wear off after 3-5 hours depending upon the dose
Adverse effects
- overdose, death[2]
- dependence, addiction
- endocarditis & other complications from contamination or non-sterile practices
- drug adverse effects of opiates
- drug adverse effects of psychotropic agents
- drug adverse effects of sedatives
Laboratory
Notes
- White house announced coordinated effort between public health & law enforcement officials to reduce heroin & prescription opioid use in certain areas of the U.S.[3]
- goal is to shift the focus toward treatment, rather than punishment of drug users
- large-scale heroin suppliers will be targeted for arrest[3]
More general terms
Additional terms
Component of
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996 pg 536, 567
- ↑ 2.0 2.1 2.2 Rudd RA et al Increases in Heroin Overdose Deaths- 2010-2012. Weekly. October 3, 2014 / 63(39);849-854 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6339a1.htm
- ↑ 3.0 3.1 3.2 The White House. Press Release. Aug. 17, 2015 White House Drug Policy Office Funds New Projects in High Intensity Drug Trafficking Areas. https://www.whitehouse.gov/the-press-office/2015/08/17/white-house-drug-policy-office-funds-new-projects-high-intensity-drug
- ↑ 4.0 4.1 Compton WM, Jones CM, Baldwin GT Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. N Engl J Med 2016; 374:154-163. January 14, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26760086 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMra1508490
Database
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=441077
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=15168
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=519045
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3592
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11221